Analysts are intrested in these 5 stocks: ( (KSS) ), ( (BILL) ), ( (NVAX) ), ( (JAZZ) ) and ( (NVDA) ). Here is a breakdown of their recent ratings and the rationale behind them.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kohl’s is making a comeback, according to analyst Charles Grom, who upgraded the stock to ‘Buy’ with a price target of $18. The company is showing signs of recovery under the leadership of CEO Michael Bender and CFO Jill Timm, with improvements in proprietary brands and sales strategies. Despite macroeconomic pressures, Kohl’s is optimistic about its future, with efforts to reconnect with its core customer base and manage inventory effectively.
Bill.com Holdings is gaining attention with a ‘Buy’ rating from analyst Scott Berg, who set a price target of $75. The company reported strong fourth-quarter results, surpassing revenue and operating income forecasts. Despite a conservative FY26 guidance, Bill.com is investing in AI financial agents and Supplier Payments Plus to enhance cross-sell and monetization, positioning itself for potential growth.
Novavax is on a new strategic path, with analyst Sean Lee giving it a ‘Buy’ rating and a $10 price target. The company’s unique vaccine platform, based on recombinant protein nanoparticles, has shown promise beyond COVID-19 vaccines. Novavax is focusing on partnerships and licensing agreements, such as its deal with Sanofi, to drive future growth while reducing commercial risks.
Jazz Pharmaceuticals is making strides with its new drug Modeyso, earning a ‘Buy’ rating from analyst Ami Fadia with a price target of $202. The drug, approved for a rare cancer, is part of Jazz’s targeted launch strategy. The company is conducting a global Phase 3 study and aims to expand its reach in the neuro-oncology market, signaling a positive outlook for investors.
Nvidia continues to impress with a ‘Buy’ rating from analyst Quinn Bolton and a $200 price target. Despite geopolitical challenges, the company reported a strong second quarter, with robust growth in its Blackwell-related products and networking segment. Nvidia’s focus on open-source models and enterprise AI adoption positions it well for future success, making it a compelling choice for investors.